In a new study, researchers found that psychological flexibility, several facets of mindfulness, and values-congruent living significantly improved following psilocybin and were maintained through week 16.
Additionally, improvements in psychological flexibility and experiential acceptance were strongly associated with reductions in depression severity following psilocybin.
Keep reading for the full article at Nature.com
Read more
Here’s another look at HPPD, Hallucinogenic persistent perception disorder.
There are two types of HPPD: type 1 is characterised by brief "flashbacks", and type 2 sufferers experience chronic symptoms that can last months or a lifetime.
Read more
In the 1960s, psychedelic research was driven underground. Now it’s re-emerging – with lessons for the study of psychosis.
Read more
This recently published study showed that psilocybin use is associated with persisting improvements in mental health and wellbeing.
Read more
This article from The Guardian states: The ketamine industry, like the wide psychedelic industry, is experiencing growing pains.
One of the largest startup clinic chains offering ketamine treatment has just gone bust, another is in dire straits, and others face uncertainty.
Why are so many ketamine clinics struggling, even as demand is increasing?
Read more
Ketamine has been around for decades but only in recent years has it found applications in mental health.
Ketamine treatments are available in two main frameworks, either with a course of psychotherapy or as a standalone medication.
Read this guide to learn more about how ketamine treatment works and how it is used in therapy.
Read more